Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiosarcoma × Immunoglobulin G × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 26 Ovarian Neoplasms 23 Carcinoma, Non-Small-Cell Lung 22 Fallopian Tube Neoplasms 21 Colorectal Neoplasms 14 Carcinoma, Renal Cell 11 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 10 Glioblastoma 10 Breast Neoplasms 10 Triple Negative Breast Neoplasms 9 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 9 Urinary Bladder Neoplasms 7 Prostatic Neoplasms 7 Brenner Tumor 7 Neoplasm Metastasis 6 Mycosis Fungoides 6 Brain Neoplasms 6 Uterine Cervical Neoplasms 5 Lymphoma, T-Cell, Cutaneous 5 Colonic Neoplasms 5 Sezary Syndrome 4 Sarcoma 4 Rectal Neoplasms 4 Multiple Myeloma 4 Gliosarcoma 4 Endometrial Neoplasms 4 Carcinoma, Transitional Cell 4 Urethral Neoplasms 3

Interventions

Doxorubicin 16 Ifosfamide 10 pazopanib 6 Radiotherapy 6 Paclitaxel 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Docetaxel 3 trebananib 2 cixutumumab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Watchful Waiting 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Conformal 2 Magnetic Resonance Spectroscopy 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡